MedPath

Effect of Co-supplementation of Curcumin and Amla in Patients with Type 2 Diabetes

Phase 3
Completed
Conditions
Type 2 diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20220902055853N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Individuals who are diagnosed with T2DM for at least one years ago
Age range from 25 to 65 years
BMI range between 25 to 34.9 kg/m2
Taking oral blood sugar lowering drugs to control diabetes
Consent to participate in the study

Exclusion Criteria

Having chronic diseases (liver, kidney, heart, thyroid, rheumatic, pulmonary, metabolic, digestive, malignancies, allergies)
Pregnancy
lactation
Insulin treatment
Taking food supplement, vitamin and mineral for at least in the last 3 months
Taking other medicinal plants routinely for at least in the last 3 months
Having a weight loss diet for at least in the last6 months
Smoking
Taking drugs or alcohol in the last 6 months
Taking steroid anti-inflammatory drugs and fiber supplements
Participate in another trial at the same time

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting blood glucose. Timepoint: At the beginning and end of study. Method of measurement: Serum sample.;Hemoglobin A1c. Timepoint: At the beginning and end of study. Method of measurement: Serum sample.;Fasting Insulin. Timepoint: At the beginning and end of study. Method of measurement: Serum sample.;Hs Crp. Timepoint: At the beginning and end of study. Method of measurement: Sample serum.;Insulin Sensitivity. Timepoint: At the beginning and end of study. Method of measurement: Formula based.;Insulin resistance. Timepoint: Aat the beginning and end of study. Method of measurement: Formula based.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath